MC38-hCLDN 18.2 (2)

Export PDF

Strain Information

Cell Line

Cat. NO.

NMC-230110

Model Description

CLDN18.2 gene humanized mouse cell line of  MC38

Strain State

Validation of tumorigenic capacity completed

Validation Data

image.png

Fig1. hCLDN18.2 expression on in vitro cultured cells of MC38-hCLDN18.2

3ad5ed216f5fac17369617124d81687.png

Fig2. hCLAUDIN18.2 expression in MC38-hCLAUDIN18.2 cell line

0415ff676493175884f456b826880b2.png

Fig3. Tumor growth curve of MC38-hCLAUDIN18.2 allogeneic model (n=4). Cells were subcutaneously inoculated into C57BL/6 mice and hCLDN18.2-Tg(NM-TG-220198) mice.

28387314e82331ef3c03c656cd70375.png

Fig4. Body weight curve of MC38-hCLAUDIN18.2 allogeneic model (n=4) (C57：6-8 week, hCLDN18.2-Tg(NM-TG-220198): 35 week)


Related Strain(s)

CT26-hCLDN 18.2 (2)
Cell Line：
Cat. NO.：NMC-230109

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more